Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry In Vivo
Biomacromolecules · 2026
DOI: 10.1021/acs.biomac.5c01157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Weijing Chu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, …. Hauptthemen laut MEDLINE: Glioblastoma, Polymers, Temozolomide, Brain Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Advance Queensland, National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
This study developed a nanoscaled system combining chemotherapeutic (Temozolomide, TMZ) and radionuclide (177Lu) for targeted glioblastoma (GBM) treatment. Bioorthogonal click chemistry was utilized to produce a selective delivery platform, and the impacts of nanomedicine structure on the efficiency of bioorthogonal reactions were explored in vivo. This was achieved by developing two parallel polymers with trans-cyclooctene (tCO) in positions differing in terms of the accessibility to the tetrazine-containing moiety. Both in vitro assessment of reaction kinetics and the in vivo distribution behavior demonstrated that tCO conjugated at the chain end of the polymer (PTtCOext) instead of those within chains (PTtCOint) exhibited better accessibility to the tetrazine-modified material ([177Lu]Lu-DPT). This then led to a more efficient click reaction in vivo and higher 177Lu accumulation in the tumor. This study provides key information on design considerations for optimal positioning of bioorthogonal reactive species in nanomedicine and a potential treatment approach for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia.
- ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals, The University of Queensland, Brisbane, Queensland 4072, Australia.
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
ORCID-Profile: Pie Huda, Christopher B Howard, Nicholas L Fletcher, Paul V Bernhardt, Kristofer J Thurecht
Förderung
- Advance Queensland
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Chu, W., Ediriweera, G. R., Prior, A., Huda, P., Lum, B., Howard, C. B., Fletcher, N. L., Bernhardt, P. V., & Thurecht, K. J. (2026). Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry In Vivo. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01157
Vancouver
Chu W, Ediriweera GR, Prior A, Huda P, Lum B, Howard CB, et al. Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry In Vivo. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c01157
BibTeX
@article{Chu2026,
author = {Chu, Weijing and Ediriweera, Gayathri R and Prior, Amber and Huda, Pie and Lum, Benedict and Howard, Christopher B and Fletcher, Nicholas L and Bernhardt, Paul V and Thurecht, Kristofer J},
title = {Pretargeted Polymeric Systems for Conducting Chemo-Radiotherapy on Glioblastoma: An Evaluation of the Impact of Nanomedicine Structure on Bioorthogonal Chemistry In Vivo},
journal = {Biomacromolecules},
year = {2026},
doi = {10.1021/acs.biomac.5c01157}
}
EUVIMED